Daniela Marino is the founder of CUTISS. CUTISS has raised $137M in total funding. Latest round: Series C. Backed by Rode Kruis Ziekenhuis.
Daniela Marino, PhD, is the Co-Founder and CEO of CUTISS, a Swiss tech-bio company specializing in personalized skin grafts. She has led the company in raising over CHF 125 million to advance its lead product, denovoSkin™, into Phase III clinical trials. CUTISS originated as a 2017 spin-off from the University of Zurich.
Full founder directory · Investor directory · Company funding database · Fundraising library